Miller Anestesia

96. Jardin F, Forest JC, Boisante L, et al: Influence of

positive end-expiratory pressure on left ventricular

performance. N Engl J Med 304:387-392, 1981.

97. Sladen A, Laver MB, Pontoppidan H: Pulmonary

complications and water retention in prolonged

mechanical ventilation. N Engl J Med 279:448-453,

1968.

98. Annat G, Viale JP, Xuan BB, et al: Effect of PEEP

ventilation on renal function, plasma renin, aldos-

terone, neurophysins and urinary ADH, and pros-

taglandins. Anesthesiology 58:136-141, 1983.

99. Venus B, Mathru M, Smith RA, et al: Renal function

during application of positive end-expiratory pres-

sure in swine: Effects of hydration. Anesthesiology

62:765-769, 1985.

100. Hemmer M, Suter PM: Treatment of cardiac and

renal effects of PEEP with dopamine in patients

with acute respiratory failure. Anesthesiology 50:

399-403, 1979.

101. Botha J, Mudholkar P, Le Blanc V: The effect of

changing from pressure support ventilation to

volume control ventilation on renal function. Crit

Care Resusc 7:303-309, 2005.

102. Imai Y, Parodo J, Kajikawa O, et al: Injurious mecha-

nical ventilation and end-organ epithelial cell apop-

tosis and organ dysfunction in an experimental

model of acute respiratory distress syndrome.

JAMA 289:2104-2112, 2003.

103. Thompson GE, Miller RD, StevensWC, et al: Hypo-

tensive anesthesia for total hip arthroplasty: A

study of blood loss and organ function, brain,

heart, liver and kidneys. Anesthesiology 48:91-96,

1978.

104. Colley PS, Silvarjan M: Regional blood flow in dogs

during halothane anesthesia and controlled hypo-

tension produced by nitroprusside or nitroglycerin.

Anesth Analg 63:503-510, 1984.

105. Aronson S, Goldberg LI, Glock D, et al: Effects of

fenoldopam on renal blood flow and systemic

hemodynamics during isoflurane anesthesia. J Car-

diothorac Vasc Anesth 5:29-32, 1991.

106. Myers BD, Moran SM: Hemodynamically media-

ted acute renal failure. N Engl J Med 314:97-105,

1986.

107. Kudo FA, Nishibe T, Miyazaki K, et al: Postoperative

renal function after elective abdominal aortic aneu-

rysm repair requiring suprarenal aortic cross-clam-

ping. Surg Today 34:1010-1013, 2004.

108. Myers SI, Wang L, Liu F, et al: Suprarenal aortic

clamping and reperfusion decreases medullary and

cortical blood flow by decreased endogenous renal

nitric oxide and PGE

synthesis. J Vasc Surg 42:524-

531, 2005.

109. Gamulin Z, Forster A, Morel D, et al: Effects of

infra-renal aortic cross-clamping on renal hemody-

namics in humans. Anesthesiology 61:394-399,

1984.

110. Burke TJ, Cronin RE, Duchin KL, et al: Ischemia and

tubule obstruction during acute renal failure in dogs:

Mannitol in protection. Am J Physiol 238:F305-

F314, 1980.

111. Pass LJ, Eberhart RC, Brown JC, et al: The effect of

mannitol and dopamine on the renal response to

thoracic aortic cross-clamping. J Thorac Cardiovasc

Surg 95:608-612, 1988.

112. Paul MD, Mazer CD, Byrick RJ, et al: Influence of

mannitol and dopamine on renal function during

elective infrarenal aortic clamping in man. Am J

Nephrol 6:427-434, 1986.

113. Mathur VS, Swan SK, Lambrecht LJ, et al: The effects

of fenoldopam, a selective dopamine receptor

agonist, on systemic and renal hemodynamics in

normotensive subjects. Crit Care Med 27:1832-

1837, 1999.

114. Miller Q, Peyton BD, Cohn EJ, et al: The effects of

intraoperative fenoldopam on renal blood flow and

tubular function following suprarenal aortic cross-

clamping. Ann Vasc Surg 17:656-662, 2003.

115. Halpenny M, Rushe C, Breen P, et al: The effects of

fenoldopam on renal function in patients under-

going elective aortic surgery. Eur J Anaesthesiol

19:32-39, 2002.

116. Higgins TL, Estafanous FG, Loop FD, et al: Stratifi-

cation of morbidity and mortality outcome by preo-

perative risk factors in coronary artery bypass

patients: A clinical severity score. JAMA 267:2344-

2348, 1992.

117. Conlon PJ, Stafford-Smith M, White WD, et al:

Acute renal failure following cardiac surgery.

Nephrol Dialysis Transplant 14:1158-1162, 1999.

118. Ip-Yam PC, Murphy S, Baines M, et al: Renal

function and proteinuria after cardiopulmonary

bypass: The effects of temperature and mannitol.

Anesth Analg 78:842-847, 1994.

119. Nakamura K, Harasaki H, Fukumura F, et al: Com-

parison of pulsatile and non-pulsatile cardiopulmo-

nary bypass on regional renal blood flow in sheep.

Scand Cardiovasc J 38:59-63, 2004.

120. Sezai A, Shiono M, Nakata K, et al: Effects of pulsa-

tile CPB on interleukin-8 and endothelin-1 levels.

Artif Organs 29:708-713, 2005.

121. Alkan T, Akcevin A, Undar A, et al: Benefits of pul-

satile perfusion on vital organ recovery during and

after pediatric open heart surgery. Asaio J 53:651-

654, 2007.

122. Onorati F, Presta P, Fuiano G, et al: A randomized

trial of pulsatile perfusion using an intra-aortic

balloon pump versus nonpulsatile perfusion on

short-term changes in kidney function during car-

diopulmonary bypass during myocardial reperfu-

sion. Am J Kidney Dis 50:229-238, 2007.

123. Abramov D, Tamariz M, Serrick CI, et al: The

influence of cardiopulmonary bypass flow cha-

racteristics on the clinical outcome of 1820 coro-

nary bypass patients. Can J Cardiol 19:237-243,

2003.

124. Woo EB, Tang AT, el-Gamel A, et al: Dopamine

therapy for patients at risk of renal dysfunction

following cardiac surgery: Science or fiction? Eur

J Cardiothorac Surg 22:106-111, 2002.

125. Abu-Omar Y, Mussa S, Naik MJ, et al: Evaluation of

Cystatin C as a marker of renal injury following

on-pump and off-pump coronary surgery. Eur

J Cardiothorac Surg 27:893-898, 2005.

126. Loef BG, Epema AH, Navis G, et al: Off-pump coro-

nary revascularization attenuates transient renal

damage compared with on-pump coronary revas-

cularization. Chest 121:1190-1194, 2002.

127. Massoudy P, Wagner S, Thielmann M, et al: Coro-

nary artery bypass surgery and acute kidney

injury—impact of the off-pump technique. Nephrol

Dial Transplant, 2008 Apr 3 [Epub ahead of print].

128. Hilberman M, Myers B, Carrie G, et al: Acute renal

failure following cardiac surgery. J Thorac Cardio-

vasc Surg 77:880-888, 1979.

129. Hilberman M, Derby GC, Spencer RJ, et al: Sequen-

tial pathophysiological changes characterizing the

progression from renal dysfunction to acute renal

failure following cardiac operation. J Thorac Car-

diovasc Surg 79:838-844, 1980.

130. Hilberman M, Maseda J, Stinson E, et al: The diu-

retic properties of dopamine in patients after

open-heart operation. Anesthesiology 61:489-494,

1984.

131. Lassnigg A, Donner E, Grubhofer G, et al: Lack of

renoprotective effects of dopamine and furosemide

during cardiac surgery. J Am Soc Nephrol 11:97-

104, 2000.

132. Myles PS, Buckland MR, Schenk NJ, et al: Effect of

“renal-dose” dopamine on renal function following

cardiac surgery. Anaesth Intensive Care 21:56-61,

1993.

133. Costa P, Ottino GM, Matani A, et al: Low-dose

dopamine during cardiopulmonary bypass in

patients with renal dysfunction. J Cardiothorac

Anesth 4:469-473, 1990.

134. MacGregor DA, Smith TE, Prielipp RC, et al: Phar-

macokinetics of dopamine in healthy male subjects.

Anesthesiology 92:338-346, 2000.

135. Chiolero R, Borgeta A, Fisher A: Postoperative arr-

hythmias and risk factors after open heart surgery.

Thorac Cardiovasc Surg 39:81-84, 1991.

136. Landoni G, Biondi-Zoccai GG, Marino G, et al:

Fenoldopam reduces the need for renal replace-

ment therapy and in-hospital death in cardiovascu-

lar surgery: A meta-analysis. J Cardiothorac Vasc

Anesth 22:27-33, 2008.

137. Caimmi PP, Pagani L, Micalizzi E, et al: Fenoldopam

for renal protection in patients undergoing cardio-

pulmonary bypass. J Cardiothorac Vasc Anesth 17:

491-494, 2003.

138. Ranucci M, Soro G, Barzaghi N, et al: Fenoldopam

prophylaxis of postoperative acute renal failure in

high-risk cardiac surgery patients.Ann Thorac Surg

78:1332-1337, discussion 1337-1338, 2004.

139. CogliatiAA,Vellutini R,NardiniA,et al: Fenoldopam

infusion for renal protection in high-risk cardiac

surgery patients: A randomized clinical study. J Car-

diothorac Vasc Anesth 21:847-850, 2007.

140. Seki G, Suzuki K, Nonaka T, et al: Effects of atrial

natriuretic peptide on glycerol induced acute renal

failure in the rat. Jpn Heart J 33:383-393, 1992.

141. Rahman SN, Kim GE, Mathew AS, et al: Effects of

atrial natriuretic peptide in clinical acute renal

failure. Kidney Int 45:1731-1738, 1994.

142. Lewis J, Salem MM, Chertow GM, et al: Atrial

natriuretic factor in oliguric acute renal failure.

Anaritide Acute Renal Failure Study Group. Am J

Kidney Dis 36:767-774, 2000.

143. Sezai A, Shiono M, Orime Y, et al: Low-dose conti-

nuous infusion of human atrial natriuretic peptide

during and after cardiac surgery. Ann Thorac Surg

69:732-738, 2000.

144. Mills RM, LeJemtel TH, Horton DP, et al: Sustained

hemodynamic effects of an infusion of nesiritide

(human b-type natriuretic peptide) in heart failure:

A randomized, double-blind, placebo-controlled

clinical trial. Natrecor Study Group. J Am Coll

Cardiol 34:155-162, 1999.

145. Colucci WS: Nesiritide for the treatment of decom-

pensated heart failure. J Card Fail 7:92-100, 2001.

146. Sackner-Bernstein JD, Skopicki HA, Aaronson KD:

Risk of worsening renal function with nesiritide in

patients with acutely decompensated heart failure.

Circulation 111:1487-1491, 2005.

147. Mentzer RM Jr, Oz MC, Sladen RN, et al: Effects of

perioperative nesiritide in patients with left ventri-

cular dysfunction undergoing cardiac surgery: The

NAPA Trial. J Am Coll Cardiol 49:716-726, 2007.

148. Burns KE, Chu MW, Novick RJ, et al: Perioperative

N-acetylcysteine to prevent renal dysfunction in

high-risk patients undergoing CABG surgery:A ran-

domized controlled trial. JAMA 294:342-350, 2005.

149. Haase M, Haase-Fielitz A, Bagshaw SM, et al: Phase

II, randomized, controlled trial of high-dose

-ace-

tylcysteine in high-risk cardiac surgery patients.

Crit Care Med 35:1324-1331, 2007.

150. Sisillo E, Ceriani R, Bortone F, et al:

-acetylcys-

teine for prevention of acute renal failure in patients

with chronic renal insufficiency undergoing cardiac

surgery: A prospective, randomized, clinical trial.

Crit Care Med 36:81-86, 2008.

Fisiología renal

241

Sección I

Fisiología y anestesia